Incorium

Incorium is a Berlin-based biotechnology company specializing in "In-Cell" drug discovery through the use of advanced Nuclear Magnetic Resonance (NMR) spectroscopy. The company's proprietary platform allows researchers to observe drug-target interactions directly within living human cells, maintaining the native physiological context often lost in traditional in vitro assays. Incorium specifically targets intrinsically disordered proteins (IDPs) and other challenging targets associated with neurodegenerative conditions such as Parkinson's disease. By providing high-resolution structural data in situ, the company aims to accelerate the development of more effective and specific small molecule therapeutics.